Aarkstore - Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

1
Aarkstore - Meningitis-Global API
Manufacturers, Marketed and Phase III Drugs
Landscape, 2015
Category Pharmaceuticals and Healthcare
2
Meningitis-Global API Manufacturers, Marketed and
Phase III Drugs Landscape, 2015, Report provides
comprehensive insights about phase III pipeline
drugs and marketed drugs across the Meningitis. A
key objective of DelveInsights report is to
establish the understanding for API Manufacturers
for marketed and Phase III Pipeline drugs across
the different countries and regions for the drugs
falling under Meningitis. The Report gives
insights into patents providing the patent
protection data and marketing exclusivity of all
the drugs across the Meningitis. While the
leading brands, companies and chemicals are
considered thoroughly, DelveInsights report also
provides details on the Global API Manufacturers
across the globe covering Drug Master
FilingsofUS, Europe and API Manufacturers in Asia
specifically China and India. The research
analysis also presents the global sales forecasts
data till 2016.
Browse Complete Report http//www.aarkstore.com
/pharmaceuticals-healthcare/97796/meningitis-globa
l-api-manufacturers-marketed-and-phase-iii-drugs-l
andscape-2015
3
Data Sources

• The report is built using data and information
  sourced from proprietary databases, primary and
  secondary research and in-house analysis by
  DelveInsight team of industry experts.
• Secondary sources information and data has been
  collected from various printable and
  non-printable sources like search engines, News
  websites, Government Websites, Trade Journals,
  White papers, Magazines, Trade associations,
  Books, Industry Portals, Industry Associations
  and access to available databases.
• Please note This report requires certain
  updates. We have all the information available
  but require 3 business days to complete the
  process and ensure it is as up-to-date as
  possible. Certain sections in the report may be
  removed or altered based on the availability and
  relevance of data for the indicated disease.

4
Scope

• A snapshot of the global Market therapeutics
  scenario for Meningitis.
• A review of the marketed products under
  prescription for Meningitis, regulatory
  information and marketing status.
• Coverage of global patent coverage and detailed
  commentaries on the US patent challenges.
• Graphical representation of investigational
  products for patent expiry and market
  exclusivities across the globe.
• Product profiles for marketed products for
  Meningitis with complete description of mechanism
  of action, therapeutic class, target, route(s) of
  administration and chemical details.
• Coverage of API Manufacturers for Meningitis
  drugs in the United States, Europe and Asian
  Regions with location details.
• Coverage of Regulatory filings in theUS, Europe,
  and Asia specifically India and China for
  Meningitis drugs.
• Coverage of Route of Synthesis of Active
  Pharmaceutical Ingredient associated with
  Meningitis drugs.

5
Reasons to buy

• Evaluate the marketing status and exclusivity
  details of Meningitis key products to exploit
  opportunities for generic drug development
  opportunities.
• Identify and understand important and diverse
  types of therapeutics under Phase III development
  for Meningitis.
• Design effective counter-strategies to gain
  competitive advantage by identifying the key
  patent expiry details and exclusivity with
  respect to Meningitis.
• API intelligence over marketed drugs for
  Meningitis and gaining primary intelligence over
  active ingredients manufacturers across the
  globe.
• API intelligence over leading Phase III Pipeline
  drugs.

6
Table of Content

• Indication Overview
• Marketed Drugs
• Marketed Details of Drugs by Application Type
• Marketed Details of Drugs (NDA) by Marketing
  Status
• Marketed Details of Drugs by Patent Expiration
  Timeline
• Active Pharmaceutical Ingredient (API)
  Manufacturers Assessment
• API Manufacturers by United States Drug Master
  File (US DMF) Status
• API Manufacturers by US DMF Status (Drug
  Specific)
• API Manufacturers in Europe by Country
• API Manufacturers in India by State
• API Manufacturers in China by Province
• Marketed Details of Approved Drugs by Geography
• Active Pharmaceutical Ingredient (API)
  Manufacturers Assessment for Phase III Pipeline
  Drugs

7
List of Tables

• Meningitis Therapeutic Market, US, Marketed Drugs
  by Application Type, 2015
• Meningitis Therapeutic Market, US, Marketed Drugs
  by Marketing Status, 2015
• Meningitis Therapeutic Market, US, (Year), 2015
• Meningitis Marketed Drugs, API Manufacturers by
  US DMF Status, 2015
• Meningitis Marketed Drugs, US DMF Status Drug
  Specific (Number), 2015
• Meningitis Drugs, API Manufacturers, Europe by
  Country, 2015
• Meningitis Drugs, API Manufacturers, India by
  State, 2015
• Meningitis Drugs, API Manufacturers, China by
  Province, 2015
• Meningitis Drugs, API Manufacturers by Geography
  2015
• Meningitis Phase III Pipeline Drugs, US DMF
  Status Drug Specific (Number), 2015
• Meningitis Therapeutic Market, Global Sales
  2012-2016 (in million USD)
• API Manufacturers for Drug, 2015
• Phase III Drugs for Meningitis, 2015
• Discontinued Drugs for Meningitis, 2015
•  
•  

8
List of Figures

• Meningitis Therapeutic Market, US, Marketed Drugs
  by Application Type (), 2015
• Meningitis Therapeutic Market, US, Marketed Drugs
  by Marketing Status (), 2015
• Meningitis Therapeutic Market, US, (Year), 2015
• Meningitis Marketed Drugs, API Manufacturers by
  US DMF Status (), 2015
• Meningitis Marketed Drugs, US DMF Status Drug
  Specific (Number), 2015
• Meningitis Drugs, API Manufacturers, Europe by
  Country, 2015
• Meningitis Drugs, API Manufacturers, India by
  State, 2015
• Meningitis Drugs, API Manufacturers, China by
  Province, 2015
• Meningitis Drugs, API Manufacturers by Geography
  2015
• Meningitis Phase III Pipeline Drugs, US DMF
  Status Drug Specific (Number), 2015

9
Related reports

• Pharmaceutical Industry Business Confidence
  Report H1 2015
• Steatohepatitis Global Clinical Trials Review,
  H1, 2015
• Post Operative Nausea And Vomiting Global
  Clinical Trials Review, H1, 2015
• Nonerosive Reflux Disease (NERD) Global Clinical
  Trials Review, H1, 2015
• Nonerosive Reflux Disease (NERD) Global Clinical
  Trials Review, H1, 2015
• Non Alcoholic Fatty Liver Disease (NAFLD) Global
  Clinical Trials Review, H1, 2015
• Patient Monitoring and Diagnostic Systems Markets
  in China
• Hearing Aids Markets in China
• Medical Imaging System and Equipment Markets in
  China
• Medical Devices Markets in China

10

• Meningitis-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015
• Published Feb 2015 100 Pages
• Meningitis-Global API Manufacturers, Marketed and
  Phase III Drugs Landscape, 2015, Report provides
  comprehensive insights about phase III pipeline
  drugs and marketed drugs across the Meningitis.
  
• Price

Format Price
PDF 2000
Site License 4000
Enterprise Wide License 6000
11
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news